ALD-52

A psychedelic compound related to LSD

ALD-52 (1-acetyl-N,N-diethyllysergamide) is a psychedelic compound that is structurally related to LSD. It is known for its psychoactive effects and has been studied for its potential therapeutic applications.

Chemical structure and properties

ALD-52 is a derivative of lysergic acid diethylamide (LSD), with an acetyl group attached to the nitrogen atom of the diethylamide moiety. This modification results in a compound that is believed to have similar effects to LSD, but with some differences in potency and duration.

The chemical formula of ALD-52 is C22H27N3O2, and it has a molecular weight of 365.47 g/mol. The compound is typically synthesized in a laboratory setting and is not found naturally.

Pharmacology

ALD-52 acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor. This action is thought to be responsible for its psychedelic effects, which include alterations in perception, mood, and cognition.

The pharmacokinetics of ALD-52 are similar to those of LSD, with effects typically beginning within 30 to 60 minutes of ingestion and lasting for 6 to 12 hours. The compound is metabolized in the liver and excreted in the urine.

Effects

The effects of ALD-52 are similar to those of LSD, including visual and auditory hallucinations, altered sense of time, and changes in thought processes. Users may experience euphoria, introspection, and spiritual experiences.

Some reports suggest that ALD-52 may have a slightly milder effect profile compared to LSD, with less anxiety and a smoother onset and offset of effects.

Legal status

The legal status of ALD-52 varies by country. In some jurisdictions, it is classified as a controlled substance, while in others it may be legal or unregulated. It is important for individuals to be aware of the laws in their area before possessing or using ALD-52.

History

ALD-52 was first synthesized by Albert Hofmann in the 1960s, during his research on lysergamides. It gained some attention in the 1960s and 1970s as a potential alternative to LSD, but it did not become as widely known or used.

In recent years, there has been renewed interest in ALD-52 and other psychedelic compounds for their potential therapeutic benefits, particularly in the treatment of mental health disorders such as depression and anxiety.

Related pages

• LSD
• Psychedelic therapy
• Serotonin receptor
• Albert Hofmann

Gallery

• 

  Chemical structure of ALD-52

• 

  Animation of ALD-52 molecule

ALD-52

• 
•